Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis

Brain Research

Volumn 952, Issue 2, 2002, Pages 159-169

  Crespel, Arielle ^a,b   Coubes, Philippe ^b   Rousset, Marie Claude ^a   Brana, Corinne ^c   Rougier, Alain ^c   Rondouin, Gérard ^a   Bockaert, Joël ^a   Baldy Moulinier, Michel ^a,b   Lerner Natoli, Mireille ^a  

^a CCIPE   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Epilepsy; Gliosis; Hippocampus; Inflammation; NF B

Indexed keywords

BRAIN ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; SYNAPTOTAGMIN;

ADULT; ANIMAL CELL; ANTIBODY LABELING; ARTICLE; BRAIN SURGERY; CELL LOSS; CELL NUCLEUS; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DENTATE GYRUS; DISEASE SEVERITY; ENCEPHALITIS; EPILEPSY; FEBRILE CONVULSION; FEMALE; GLIA CELL; GLIOSIS; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SURGICAL TECHNIQUE; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 0037131063     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03050-0     Document Type: Article

References (33)

1. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NF-kappaB-dependent mechanism. Proc. Natl. Acad. Sci. USA. 95:1998;5795-5800.
2. Aronowski J., Strong R., Kang H.S., Grotta J.C. Selective up-regulation of I kappaB-alpha in ischemic penumbra following focal cerebral ischemia. NeuroReport. 11:2000;1529-1533.
3. Beaurain J., Clemenceau S., Duyckaerts C., Benavides J., Baulac M., Hauw J.J., Philippon J. Morphometric and radioautographic study of neuronal loss and gliosis in sclerosis of the hippocampus associated with temporal lobe epilepsy. Chirurgie. 120:1994-1995;486-493.
4. Blank V., Kourilsky P., Israel A. NFκB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci. 17:1992;135-140.
5. Blondeau N., Widmann C., Lazdunski M., Heurteaux C. Activation of the Nuclear Factor-κB is a key event in brain tolerance. J. Neurosci. 21:2001;4668-4677.
6. Bouchet C., Cazauvieilh P. De l'épilepsie considérée dans ses rapports avec l'aliénation mentale. Arch. Gen. Med. 9:1825;510-542.
7. Chao C.C., Lokensgard J.R., Sheng W.S., Hu S., Peterson P.K. IL-1-induced iNOS expression in human astrocytes via NF-κB. NeuroReport. 8:1997;3163-3166.
8. Clemens J.A. Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic. Biol. Med. 28:2000;1526-1531.
9. Clemens J.A., Stephenson D.T., Dixon E.P., Smalstig E.B., Mincy R.E., Rash K.S., Little S.P. Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res. Mol. Brain Res. 48:1997;187-196.
10. De Bock F., Dornand J., Bockaert J., Rondouin G. Release of TNFα in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. NeuroReport. 7:1996;1125-1129.
11. Heils A., Haig K., Kunz W.S., et al. Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann. Neurol. 48:2000;948-949.
12. Houser C. Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res. 535:1990;195-204.
13. Ichiyama T., Okada K., Lipton J.M., Matsubara T., Hayashi T., Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 857:2000;246-251.
14. Irving E.A., Hadingham S.J., Roberts J., Gibbons M., Chabot-Fletcher M., Roshak A., Parsons A.A. Decreased nuclear factor-kappaB DNA binding activity following permanent focal cerebral ischemia in the rat. Neurosci. Lett. 288:2000;45-48.
15. Jankowsky J.L., Patterson P.H. The role of cytokines and growth factors in seizures and their sequelae. Progr. Neurobiol. 63:(2):2001;125-149. Review.
16. Kanemoto K., Kawasaki J., Miyamoto O., Bayashi H., Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphism in patients with temporal lobe epilepsy. Ann. Neurol. 47:2000;571-574.
17. Kuner P., Schubenel R., Hertel C.J. Beta-amyloid binds to p57NTR and activates NFκB in human neuroblastoma cells. Neurosci. Res. 54:1998;798-804.
18. Lerner-Natoli M., Montpied P., Rousset M.C., Bockaert J., Rondouin G. Sequential expression of surface antigens and transcription factor NFκB by hippocampal cells in excitotoxicity and experimental epilepsy. Epilepsy Res. 41:2000;141-154.
19. Loup F., Weinmann O., Yonekawa Y., Aguzzi A., Wieser H.G., Fritschy J.M.J. A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABA-A receptor subunits in the human brain. Histochem. Cytochem. 46:1998;1129-1139.
20. Mattson M.P., Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107:2001;247-254.
21. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1beta, IL-6, TNFalpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 176:1991;593-598.
22. Miyamoto S., Verma I.M. Rel/NFκB/IκB story. Adv. Cancer Res. 66:1995;255-292.
23. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukine-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31:1998;129-133.
24. Plata-Salaman C.R., Ilyin S.E., Turrin N.P., et al. Kindling modulates the IL-1β system, TNFα, TGF-β1 and neuropeptide mRNAs in specific brain regions. Mol. Brain Res. 75:2000;248-258.
25. Represa A., Niquet J., Pollard H., Ben-Ari Y. Cell death, gliosis and synaptic remodeling in the hippocampus of epileptic rats. J. Neurobiol. 26:1995;413-425.
26. Shaw J.A., Perry V.H., Mellanby J. MHC class II expression by microglia in tetanus toxin-induced experimental epilepsy in the rat. Neuropathol. Appl. Neurobiol. 20:1994;392-398.
27. Sommer W. Erkrankung des ammonshorns als ätiologisches moment der epilepsie. Arch. Psychiatr. Nervenkr. 10:1880;631-675.
28. Taniwaki Y., Kato M., Araki T., Kobayashi T. Microglial activation by epileptic activities through the propagation pathway of kainic acid-induced hippocampal seizures in the rat. Neurosci. Lett. 217:1996;29-32.
29. Terai K., Matsuo A., McGeer P.L. Enhancement of immunoreactivity for NFκB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 735:1996;159-168.
30. Terai K., Matsuo A., McGeer E.D., McGeer P.L. Enhancement of immunoreactivity for NF-κB in human cerebral infarctions. Brain Res. 739:1996;343-349.
31. Vezzani A., Conti M., De Luigi A., et al. Interleukine-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19:1999;5054-5065.
32. Vezzani A., Moneta D., Conti M., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. USA. 97:2000;11534-11539.
33. Zimmer L.A., Ennis M., Shipley M.T. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain region. J. Comp. Neurol. 378:1997;482-492.